Table 4.
OR | 95% CI | OR adj | 95% CI | p value | |
---|---|---|---|---|---|
Age at survey (years) | 1.04 | 1.01–1.07 | 1.03 | 0.98–1.08 | 0.33 |
Body Mass Index (kg/m2) | 0.96 | 0.92–0.99 | 1.01 | 0.94–1.09 | 0.75 |
Physically inactive | 0.47 | 0.33–0.68 | 0.61 | 0.32–1.18 | 0.14 |
Number of visits to the GP | 0.69 | 0.61–0.79 | 0.85 | 0.72–1.01 | 0.07 |
Support | |||||
Current social support at work (DCQS) | 0.81 | 0.76–0.87 | 0.98 | 0.85–1.13 | 0.78 |
Cancer-specific social support (SFSS) | |||||
Supervisor support | 1.09 | 1.04–1.14 | 0.96 | 0.86–1.07 | 0.45 |
Colleague support | 1.16 | 1.10–1.22 | 1.16 | 1.02–1.31 | 0.03 |
Cancer-related variables | |||||
Receiving chemotherapy (ref: no) | 0.35 | 0.24–0.52 | 0.63 | 0.29–1.36 | 0.24 |
Receiving endocrine treatment (ref: no) | 0.65 | 0.45–0.93 | 0.97 | 0.48–1.95 | 0.93 |
Health related quality of life | |||||
Sleep problems (ref: no) | 0.43 | 0.29–0.62 | 0.75 | 0.37–1.50 | 0.41 |
Neuropathy (ref: no) | 0.30 | 0.16–0.55 | 0.92 | 0.30–2.83 | 0.88 |
Fatiguea | 0.94 | 0.93–0.95 | 0.96 | 0.94–0.99 | < 0.01 |
Cognitive functiona | 1.06 | 1.05–1.08 | 1.03 | 1.01–1.05 | 0.02 |
Pain intensitya | 0.96 | 0.94–0.97 | 0.99 | 0.97–1.01 | 0.35 |
Arm symptomsa | 0.96 | 0.94–0.97 | 0.98 | 0.96–1.01 | 0.15 |
Breast symptomsa | 0.96 | 0.94–0.97 | 0.99 | 0.96–1-02 | 0.49 |
Depressionb | 0.75 | 0.70–0.80 | 1.12 | 0.97–1.29 | 0.12 |
Fear of cancer recurrencec | 0.93 | 0.91–0.96 | 0.99 | 0.95–1.03 | 0.55 |
DCSQ demand control support questionnaire, SFSS social functional support scale, OR odds ratio, CI confidence interval, adj adjusted, GP general practitioner, ref reference
aScale 0–100
bScale 0–27
cScale 0–40. Only univariate analyses with significance level of ≤ 0.2, are shown here. Significant adjusted associations are highlighted in bold